Apoptosis in cardiac diseases - New opportunities for novel therapeutics for heart diseases

Cardiovascular Drugs and Therapy

Volumn 13, Issue 4, 1999, Pages 289-294

  Feuerstein, Giora Z ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; CARVEDILOL; CERAMIDE; CYTOKINE; FAS LIGAND; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; NITROGEN OXIDE; OXYGEN RADICAL; RECEPTOR; SPHINGOLIPID;

ANIMAL CELL; APOPTOSIS; CELL DEATH; EDITORIAL; HEART ARRHYTHMIA; HEART DISEASE; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; CASPASES; CYTOKINES; ENERGY INTAKE; GROWTH SUBSTANCES; HEART DISEASES; HUMANS; PROTEIN KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 0032868026     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007735413477     Document Type: Editorial

References (16)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
2. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 1993;75: 641-652.
3. Anversa P, Leri A, Beltrami CA, Guerra S, Kajstura J. Myocyte death and growth in failing heart. Lab Invest 1998;78:767-786.
4. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A. Apoptosis in myocytes in end-stage heart failure. New Engl J Med 1996;335:1182-1189.
5. Haunstetter A, Izumo S. Apoptosis-basic mechanisms and implications for cardiovascular disease. Circ Res 1998;82: 1111-1129.
6. Yaoita H, Ogawa K, MaeLare K, Maruyama Y. Attenuation of ischemia/repercussion injury in rats by a caspase inhibitor. Circulation 1998;97:276-281.
7. Yue T-L, Ma X-L, Wang X-K, Romanie Am, Liu G-L, Louden C, Gu J-L, Kumai S, Poste G, Ruffolo RR Jr., Feuerstein GZ. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res 1998;52:166-174.
8. jblockade with losartan. Hypertension 1998;32:280-286.
9. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteolysis. Cell 1997;91:443-446.
10. Black SC, Huang JQ, Rezaiefar P, Rodinovic S, Eberhardt A, Nicholson DW, Rodger IW. Co-Localization of the cystein protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in rats. J Mol Cell Cordial 1998;30:733-742.
11. Adams JW, Sokata Y, Davis MG, Sah V, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW. Enhanced Gag. Proc Natl Acad Sci 1998;95:10140-10145.
12. Hofmann K, Dixit VM. Ceramide in apoptosis-does it really matter? Trends in Biochem Science 1998;374-377.
13. Kirshenbaum LA, Meissac D. The bcl-z gene product prevents programmed cell death of ventricular myocytes. Circulation 1997;96:1580-1585.
14. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler SM, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994;372:739-746.
15. Ma X-L, Kumar S, Gao F, Louden C, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein G, Yue T-L. Inhibition of p38 mitogen activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999;99: 1685-1691.
16. Feuerstein GZ, Shusterman NH, Ruffolo R.R. Jr. Carvedilol Update IV: Prevention of oxidative stress and cardiac remodeling in heart failure progression. Drug of Today 1997;33:453-473.